MediGene AG (MDGEF)
0.10
0.00 (0.00%)
USD |
OTCM |
Oct 16, 16:00
MediGene Cash from Operations (Annual)
Cash from Operations (Annual) Chart
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | -16.35M |
| December 31, 2022 | 12.59M |
| December 31, 2021 | -12.71M |
| December 31, 2020 | -28.26M |
| December 31, 2019 | -18.38M |
| December 31, 2018 | -11.96M |
| December 31, 2017 | -23.52M |
| December 31, 2016 | -4.157M |
| December 31, 2015 | -11.76M |
| December 31, 2014 | -11.61M |
| December 31, 2013 | -16.26M |
| December 31, 2012 | -8.358M |
| December 31, 2011 | 9.546M |
| December 31, 2010 | -15.10M |
| Date | Value |
|---|---|
| December 31, 2009 | -26.14M |
| December 31, 2008 | -37.83M |
| December 31, 2007 | -43.94M |
| December 31, 2006 | -1.669M |
| December 31, 2005 | -12.96M |
| December 31, 2004 | -15.03M |
| December 31, 2003 | -30.00M |
| December 31, 2002 | -36.43M |
| December 31, 2001 | -19.69M |
| December 31, 2000 | -6.236M |
| December 31, 1999 | -3.359M |
| December 31, 1998 | -2.336M |
| December 31, 1997 | -1.261M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| InflaRx NV | -39.86M |
| BioNTech SE | 514.63M |
| Immatics NV | -199.34M |
| Arrowhead Pharmaceuticals, Inc. | 179.55M |
| Oncolytics Biotech, Inc. | -20.11M |